Chaeum Premium No. 3: Understanding Regulatory Status for Professional Sourcing

Chaeum Premium No. 3 is a hyaluronic acid (HA) dermal filler manufactured by Hugel in South Korea. Designed for professional aesthetic applications, it is part of a range of HA fillers aimed at various indications. When sourcing any hyaluronic acid dermal filler catalog, practitioners prioritize product consistency, manufacturer reputation, and clear regulatory documentation. Illustrative wholesale pricing for Chaeum Premium No. 3 typically begins around $96.8 per unit, with volume tiers offering progressive discounts: 11 units (4% off), 21 units (5% off), 31 units (6% off), and 51+ units (8% off).

The regulatory landscape for medical devices, including hyaluronic acid dermal fillers, varies significantly across global markets. Key designations to consider for products like Chaeum Premium No. 3 often include: KFDA (South Korea), CE Mark (European Union), and FDA (United States). These certifications indicate that a product meets specific safety, quality, and efficacy standards for distribution within their respective jurisdictions. For instance, understanding the specific regulatory pathways for different products is crucial, as highlighted in guides like Re N Tox 100unit: Navigating Regulatory Status for Professio.

As a product originating from South Korea, Chaeum Premium No. 3 by Hugel is manufactured under the stringent regulations of the Korean Ministry of Food and Drug Safety (KFDA). KFDA approval confirms that the product adheres to national safety and quality standards for medical devices. Furthermore, manufacturing facilities are typically subject to Good Manufacturing Practice (GMP) standards, which ensure consistent production quality and control. Professionals should verify the current KFDA approval and GMP compliance status with their suppliers.

For distribution within the European Union and the United Kingdom, products like Chaeum Premium No. 3 often seek CE Mark certification. A CE Mark indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). The status of Chaeum Premium No. 3's CE Mark [VERIFY: CE Mark status for Chaeum Premium No. 3 should be confirmed with the manufacturer or authorized distributor for specific variants]. Clinics in these regions should confirm that any imported stock carries the appropriate CE certification for legal use. Different HA fillers have distinct regulatory journeys, as seen with products such as Elasty Plus 1CC.

FDA approval by the U.S. Food and Drug Administration is a distinct and often lengthy process, primarily relevant for market access in the United States. [VERIFY: FDA approval status for Chaeum Premium No. 3]. Many Korean-manufactured fillers focus on other international markets before, or instead of, the U.S. In regions like the GCC (Gulf Cooperation Council), LATAM (Latin America), and APAC (Asia-Pacific), market access for Chaeum Premium No. 3 is governed by each country's specific health authority regulations. These can range from recognition of KFDA/CE to requiring local registration processes. Practitioners should confirm local import and usage regulations.

When sourcing Chaeum Premium No. 3, professionals must exercise diligence, particularly concerning parallel imports. While not inherently illegal, parallel imports can complicate traceability and warranty claims if not managed through reputable channels. Always demand documentation that confirms the product's origin, lot numbers, and regulatory compliance in your specific market. This practice is vital for any aesthetic injectable, similar to considerations for products like EPTQ S300 Regulatory Status: Key Considerations for Professi.

To ensure compliance and patient safety, clinics should demand comprehensive documentation from their wholesale suppliers. This includes: original manufacturer's certificates of authenticity, batch/lot specific certificates, and proof of cold chain maintenance during transit. Verify that the product packaging includes clear expiration dates and tamper-evident seals. Understanding the complete paper trail from manufacturer to clinic is paramount for professional integrity and regulatory adherence.